Prevalence of Impaired Fasting Glucose and Type 2 Diabetes in Kazakhstan
Findings From Large Study
Bibliographic Data
| ID | 22079906 |
|---|---|
| Authors | Binur Orazumbekova (0000-0002-9640-3714, Nazarbayev University), Alpamys Issanov (0000-0002-8968-2655, Nazarbayev University, corresponding author), Kuralay Atageldiyeva (0000-0002-7048-1511, Nazarbayev University), Salim Berkinbayev (0000-0003-2489-8276, Kazakh National Medical University), Gulnara Junusbekova (0000-0001-7452-5625, Kazakhstan Medical University), Laura Danyarova (0000-0002-5162-8135, Kazakh National Medical University), Zhanmedet Shyman (Kazakh National Medical University), Akmaral Tashmanova (0000-0001-7627-0283), Antonio Sarria-Santamera, Antonio Sarría‐Santamera (0000-0001-5734-7468, Nazarbayev University, corresponding author) |
| Year | 2022 |
| Volume | 10 |
| Pages | 810153-810153 |
| Publication date | 2022-02-24 |
| Open Access | Yes |
| Type | ARTICLE |
| Venue | Frontiers in Public Health (JOURNAL) |
| Journal identifiers | ISSN: 2296-2565 • E-ISSN: 2296-2565 |
| Publisher | Frontiers Media SA (PUBLISHER • CH) |
| DOI | 10.3389/fpubh.2022.810153 |
| PMID | 35284393 |
| OpenAlex | W4213437590 |
| Language | EN |
| Citations received | 1 |
| References cited | 35 |
Type 2 diabetes mellitus (T2DM) is a serious public health problem. A large proportion of patients with T2DM are unaware of their condition. People with undiagnosed T2DM are at a greater risk of developing complications, whereas prediabetes has an elevated risk of becoming T2DM. The aim of this study is to estimate the prevalence of impaired fasting glucose (IFG), undiagnosed and prior-diagnosed T2DM in Kazakhstan. A cross-sectional study was conducted in four geographically remote regions using the WHO STEP survey instrument. The status of T2DM of 4,753 participants was determined using the WHO diagnostic criteria based on fasting plasma glucose (FPG) level. As a result, the survey-weighted prevalence of IFG was 1.9% (95% CI 1.1%; 3.5%) and of T2DM was 8.0% (95% CI 3.8; 15.9). A total of 54% of T2DM have been newly diagnosed with T2DM. Being 55–64 years old (OR = 2.71, 95% CI 1.12; 6.60) and having lowered HDL-C level (OR = 3.72, 95% CI 1.68; 8.23) were found to be independent predictors for IFG. Being older than 45 years, a female (OR = 0.57, 95% CI 0.39; 0.83), having high waist circumference, was associated with newly diagnosed T2DM. Whereas, the age older than 45 years, high waist circumference, and family history of diabetes (OR = 2.42, 95% CI 1.64; 3.54) were associated with preexisting T2DM. This study shows a high prevalence of IFG and a high proportion of newly diagnosed T2DM in Kazakhstan. A series of risk factors identified in the study may be used to strengthen appropriate identification of IFG or undiagnosed patients in healthcare settings to deliver either preventive or therapeutic interventions aimed to reduce the incidence of T2DM or the delay of their complications. Further longitudinal studies are needed to confirm these associations in our population
Diabetes mellitus · Environmental health · Fasting glucose · Impaired fasting glucose · Impaired glucose tolerance · Insulin resistance · Type 2 diabetes · Diabetes Management and Research · Diabetes, Cardiovascular Risks, and Lipoproteins · Liver Disease Diagnosis and Treatment · Medicine · Endocrinology · Internal Medicine · Physiology
Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045
Classification and Diagnosis of Diabetes
The Effect of Rural-to-Urban Migration on Obesity and Diabetes in India
Gender differences in health information behaviour
Levels and distribution of self-rated health in the Kazakh population
Inequalities in self-rated health among 45+ year-olds in Almaty, Kazakhstan
Prevalence and comorbidity of diabetes mellitus among non-institutionalized older adults in Germany - results of the national telephone health interview survey ‘German Health Update (Geda)’ 2009
The World Health Organization STEPwise Approach to Noncommunicable Disease Risk-Factor Surveillance
| Citations per year | 0.5 |
|---|---|
| Citation span | 2024 - 2024 (1) |
| Highly cited | No |